Skip to content

Thermo Fisher Scientific Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 21, 2026 results vs estimates

Thermo Fisher Scientific Inc · E.TMO.NYSE · United States
Use symbol E.TMO.NYSE in our API & Excel add-in to retrieve this data ↓
709.18
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 26.87%

Thermo Fisher Scientific Inc Forecast

Thermo Fisher Scientific Inc short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 26.9% a year, a typical one-standard-deviation range is 682.34–736.02 over a week, 654.18–764.18 over a month and 518.65–899.71 over a year. (Signals as of 1 Nov 2026.)

Thermo Fisher Scientific Inc Price Chart

MacroFinance.ai

Thermo Fisher Scientific Inc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Thermo Fisher Scientific Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Thermo Fisher Scientific Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Thermo Fisher Scientific Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Thermo Fisher Scientific Inc
P/E
37.15x
Stretched vs own history
QoQ +11.0%
YoY +9.9%
now 37.146123.84 low37.15 high
ⓘP/E As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Thermo Fisher Scientific Inc
P/S
5.56x
Stretched vs own history
QoQ +10.3%
YoY +9.4%
now 5.55653.62 low5.56 high
ⓘP/S As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Thermo Fisher Scientific Inc
P/B
4.80x
Mid-range vs own history
QoQ +8.4%
YoY +10.4%
now 4.80453.15 low4.86 high
ⓘP/B As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Thermo Fisher Scientific Inc
EV/EBITDA
26.55x
Stretched vs own history
QoQ +12.9%
YoY +18.3%
now 26.54717.74 low26.55 high
ⓘEV/EBITDA As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Thermo Fisher Scientific Inc
EV/Sales
6.30x
Stretched vs own history
QoQ +7.4%
YoY +8.4%
now 6.30224.5 low6.36 high
ⓘEV/Sales As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Thermo Fisher Scientific Inc
FCF Yield
2.9%
Mid-range vs own history
QoQ −7.9%
YoY +4.9%
now 2.88712.58 low4.13 high
ⓘFCF Yield As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Thermo Fisher Scientific Inc
Earnings Yield
2.7%
Weak vs own history
QoQ −9.9%
YoY −9.0%
now 2.69212.69 low4.2 high
ⓘEarnings Yield As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Thermo Fisher Scientific Inc
Dividend Yield
0.3%
Mid-range vs own history
QoQ −9.8%
YoY −8.8%
now 0.25580.26 low0.4 high
ⓘDividend Yield As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Thermo Fisher Scientific Inc
Market Cap
$263.1B
Highest in 5 years
QoQ +12.7%
YoY +18.5%
now 263105.78163,501 low263,106 high
ⓘMarket Cap As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Thermo Fisher Scientific Inc
Net Debt
$35.3B
High vs own history
QoQ −8.3%
YoY +9.9%
now 3530929,280 low39,905 high
ⓘNet Debt As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Thermo Fisher Scientific Inc
Net Debt / EBITDA
3.14x
High vs own history
QoQ −5.6%
YoY +10.7%
now 3.14112.55 low3.48 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Thermo Fisher Scientific Inc
Current Ratio
1.81x
Strong vs own history
QoQ +16.6%
YoY +20.7%
now 1.80771.5 low1.89 high
ⓘCurrent Ratio As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Thermo Fisher Scientific Inc
Quick Ratio
1.41x
Strong vs own history
QoQ +19.7%
YoY +26.8%
now 1.40951.11 low1.53 high
ⓘQuick Ratio As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Thermo Fisher Scientific Inc
Interest Coverage
5.83x
Mid-range vs own history
QoQ −0.9%
YoY −1.8%
now 5.82955.83 low6.13 high
ⓘInterest Coverage As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Thermo Fisher Scientific Inc
Debt / Equity
0.76x
Mid-range vs own history
QoQ −6.5%
YoY +8.0%
now 0.75550.7 low0.83 high
ⓘDebt / Equity As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Thermo Fisher Scientific Inc
Piotroski F-Score
8
Mid-range vs own history
QoQ +60.0%
YoY 0.0%
now 85 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Thermo Fisher Scientific Inc
Altman Z-Score
4.23
Mid-range vs own history
QoQ +10.3%
YoY +2.3%
now 4.22953.08 low4.3 high
ⓘAltman Z-Score As of 22 Nov 2026.See Thermo Fisher Scientific Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Thermo Fisher Scientific Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Thermo Fisher Scientific Inc fundamentals: income statement, balance sheet & cash flow

Thermo Fisher Scientific Inc reported revenue of $44.56bn and net income of $6.74bn in FY2025, the year ended 31 December 2025 — revenue up 3.9% and net income up 6.3% on the prior year. Free cash flow was $6.29bn. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$44.56bn
+3.9%
Net income
$6.74bn
+6.3%
Gross margin
40.93%
Free cash flow
$6.29bn
-13.4%
Net debt
$29.53bn
Shares short (30 Oct 2026)
4.78m
1.97 days to cover
Thermo Fisher Scientific Inc income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue44.5642.8842.8644.9239.21
Cost of revenue26.3225.1525.3025.9019.58
Gross profit18.2417.7317.5619.0119.63
Research & development1.401.391.341.471.41
Selling, general & admin.—8.60———
Operating income8.117.666.868.5310.32
EBITDA11.4711.806.8611.9411.97
Interest expense1.421.651.380.730.54
Pre-tax income7.277.006.307.668.84
Income tax0.550.66-0.280.701.11
Net income6.746.346.006.957.73

Download Thermo Fisher Scientific Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.TMO.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Thermo Fisher Scientific Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Thermo Fisher Scientific Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Thermo Fisher Scientific Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Thermo Fisher Scientific Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Thermo Fisher Scientific Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Thermo Fisher Scientific Inc (United States)

Thermo Fisher Scientific Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Thermo Fisher CDR (CAD Hedged)

Frequently asked questions

What is Thermo Fisher Scientific Inc?
Thermo Fisher Scientific Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Thermo Fisher Scientific Inc price?
The latest close is 709.18 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Thermo Fisher Scientific Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Thermo Fisher Scientific Inc?
20-day realised volatility is 26.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 7.8% over a month and 3.8% over a week.
What factors affect Thermo Fisher Scientific Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Thermo Fisher Scientific Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Thermo Fisher Scientific Inc?
58 backtested tactical asset allocation strategies trade Thermo Fisher Scientific Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Thermo Fisher Scientific Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Thermo Fisher Scientific Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Thermo Fisher Scientific Inc historical data?
In the Free historical data section of this page: the last 10 years of Thermo Fisher Scientific Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Thermo Fisher Scientific Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Thermo Fisher Scientific Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.TMO.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20669.54
2026-11-19688.75
2026-11-18692.74
2026-11-17686.79
2026-11-16691.33
2026-11-13700.22
2026-11-12699.44
2026-11-11717.71
2026-11-10718.2
2026-11-09721.63
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.